Ein Nanobody gegen Herpes

🤖 Can algorithms outsmart evolution to create therapies humans never imagined?

🔗 Computational nanobody design through deep generative modeling and epitope landscape profiling. Computational and Structural Biotechnology Journal, DOI: https://doi.org/10.1016/j.csbj.2025.07.052

📚 CSBJ: https://www.csbj.org/

#Nanobody #AI #DeepLearning #ProteinDesign #DrugDiscovery #ComputationalBiology #GenerativeAI #Immunotherapy #COVID19 #SARSCoV2 #Omicron #AntibodyEngineering #SyntheticBiology #TranslationalResearch

Nanobody neutralizes deadly Nipah and Hendra viruses in lab tests

Researchers have discovered a strategy to neutralize two highly lethal viruses for which there is currently no approved vaccine or cure.

Phys.org
A #nanobody-based #therapeutic targeting #Nipah virus limits viral escape

Nanobody neutralizes deadly Nipah and Hendra viruses in lab tests

Researchers have discovered a strategy to neutralize two highly lethal viruses for which there is currently no approved vaccine or cure.

Phys.org
Identification and characterization of a broadly neutralizing and protective #nanobody against the #HA1 domain of #H5 avian #influenza virus #hemagglutinin, https://etidiohnew.blogspot.com/2025/04/identification-and-characterization-of.html
Identification and characterization of a broadly neutralizing and protective #nanobody against the #HA1 domain of #H5 avian #influenza virus #hemagglutinin

"The Virtual Lab: AI Agents Design New SARS-CoV-2 Nanobodies with Experimental Validation"

We demonstrate the power of the Virtual Lab by applying it
to design nanobody binders to recent variants of SARS-CoV-2, which is a challenging,
open-ended research problem that requires reasoning across diverse fields from biology to
computer science.

https://www.biorxiv.org/content/10.1101/2024.11.11.623004v1

#COVID #AIMedicine #nanobody #VirtualLab

#Influenza A Virus #H7 #nanobody recognizes a conserved immunodominant epitope on #hemagglutinin head and confers heterosubtypic #protection

Source: BioRxIV, AbstractInfluenza remains a persistent global health challenge, largely due to the virus continuous antigenic drift and shift, which impede the development of a universal vaccine. To address this, the identification of broadly neutralizing antibodies and their epitopes is crucial. Nanobodies, with their unique…

https://etidioh.wordpress.com/2024/11/01/influenza-a-virus-h7-nanobody-recognizes-a-conserved-immunodominant-epitope-on-hemagglutinin-head-and-confers-heterosubtypic-protection/

#Influenza A Virus #H7 #nanobody recognizes a conserved immunodominant epitope on #hemagglutinin head and confers heterosubtypic #protection

Source: BioRxIV, AbstractInfluenza remains a persistent global health challenge, largely due to the virus continuous antigenic drift and shift, which impede the development of a universal vaccine. …

ETIDIoH
2018 erhielt mit Caplacizumab der erste therapeutische #Nanobody die Zulassung. Trotz einiger zwischenzeitlicher Pleiten könnten bald weitere folgen … Kathleen Gransalke fasst den Stand der Dinge zusammen: https://www.laborjournal.de/editorials/3014.php
Nanobody Sonelokimab in entscheidender klinischen Phase

weiterer folgen ...

Laborjournal